

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 9.24627996 |
| 2 | cytidine catabolic process (GO:0006216) | 9.24627996 |
| 3 | cytidine deamination (GO:0009972) | 9.24627996 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 9.08248094 |
| 5 | DNA deamination (GO:0045006) | 8.86908630 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 8.21316261 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 6.77180377 |
| 8 | actin nucleation (GO:0045010) | 5.94574383 |
| 9 | T cell migration (GO:0072678) | 4.71485020 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.69502929 |
| 11 | sequestering of actin monomers (GO:0042989) | 4.67590565 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 4.58438674 |
| 13 | negative regulation by host of viral transcription (GO:0043922) | 4.35614869 |
| 14 | negative T cell selection (GO:0043383) | 4.29850951 |
| 15 | regulation of regulatory T cell differentiation (GO:0045589) | 4.24136643 |
| 16 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.16597565 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.11596192 |
| 18 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.09192506 |
| 19 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.03577275 |
| 20 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.01845067 |
| 21 | negative regulation of T cell apoptotic process (GO:0070233) | 3.94958283 |
| 22 | positive T cell selection (GO:0043368) | 3.87061791 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 3.86498439 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85290675 |
| 25 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.83557148 |
| 26 | positive thymic T cell selection (GO:0045059) | 3.79167869 |
| 27 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.79039913 |
| 28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.74017866 |
| 29 | positive regulation of defense response to virus by host (GO:0002230) | 3.68262372 |
| 30 | cytolysis (GO:0019835) | 3.60779933 |
| 31 | negative regulation of viral genome replication (GO:0045071) | 3.60107417 |
| 32 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.58514157 |
| 33 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.58514157 |
| 34 | regulation of activation of Janus kinase activity (GO:0010533) | 3.58399775 |
| 35 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.53040674 |
| 36 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.52057809 |
| 37 | eosinophil chemotaxis (GO:0048245) | 3.51257179 |
| 38 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.46783485 |
| 39 | negative thymic T cell selection (GO:0045060) | 3.46767554 |
| 40 | positive regulation of cell killing (GO:0031343) | 3.45200341 |
| 41 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.44525758 |
| 42 | protein neddylation (GO:0045116) | 3.43169610 |
| 43 | response to interleukin-15 (GO:0070672) | 3.38627934 |
| 44 | regulation of B cell differentiation (GO:0045577) | 3.37919720 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36556601 |
| 46 | positive regulation of tolerance induction (GO:0002645) | 3.32492614 |
| 47 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.29472559 |
| 48 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.27214413 |
| 49 | T cell receptor signaling pathway (GO:0050852) | 3.26996879 |
| 50 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.23506418 |
| 51 | regulation of interleukin-8 secretion (GO:2000482) | 3.23080309 |
| 52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.22757048 |
| 53 | regulation of cell killing (GO:0031341) | 3.22748276 |
| 54 | macrophage chemotaxis (GO:0048246) | 3.22156567 |
| 55 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.21676752 |
| 56 | thymic T cell selection (GO:0045061) | 3.19700489 |
| 57 | eosinophil migration (GO:0072677) | 3.19351683 |
| 58 | regulation of T cell tolerance induction (GO:0002664) | 3.17673114 |
| 59 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.17191902 |
| 60 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.17191902 |
| 61 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.14190650 |
| 62 | DNA demethylation (GO:0080111) | 3.12258874 |
| 63 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.10726634 |
| 64 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.10726634 |
| 65 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.09175564 |
| 66 | iron-sulfur cluster assembly (GO:0016226) | 3.09016613 |
| 67 | metallo-sulfur cluster assembly (GO:0031163) | 3.09016613 |
| 68 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.08430311 |
| 69 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.08430311 |
| 70 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.08430311 |
| 71 | lymphocyte chemotaxis (GO:0048247) | 3.07214553 |
| 72 | T cell costimulation (GO:0031295) | 3.05975928 |
| 73 | negative regulation of stress fiber assembly (GO:0051497) | 3.03545069 |
| 74 | lymphocyte costimulation (GO:0031294) | 3.02258015 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95019394 |
| 76 | regulation of chronic inflammatory response (GO:0002676) | 2.93845039 |
| 77 | negative regulation of B cell proliferation (GO:0030889) | 2.91540548 |
| 78 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.90664945 |
| 79 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.89466463 |
| 80 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.89183175 |
| 81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.89183175 |
| 82 | mast cell activation (GO:0045576) | 2.89120688 |
| 83 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88328951 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.87766729 |
| 85 | regulation of defense response to virus by host (GO:0050691) | 2.87325995 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.86984978 |
| 87 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.86581899 |
| 88 | T cell selection (GO:0045058) | 2.86549183 |
| 89 | platelet dense granule organization (GO:0060155) | 2.85761379 |
| 90 | lymphocyte migration (GO:0072676) | 2.84669447 |
| 91 | regulation of viral genome replication (GO:0045069) | 2.81812170 |
| 92 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.79780149 |
| 93 | DNA dealkylation (GO:0035510) | 2.79456257 |
| 94 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.79433293 |
| 95 | mast cell activation involved in immune response (GO:0002279) | 2.79322827 |
| 96 | mast cell degranulation (GO:0043303) | 2.79322827 |
| 97 | response to interferon-beta (GO:0035456) | 2.78833585 |
| 98 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.75713741 |
| 99 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.74521637 |
| 100 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.73486529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.70718273 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.88642821 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.83789349 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.65211914 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.65114429 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.60035522 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.06663875 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.00471399 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.00405161 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.97231797 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.61463002 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.40118241 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.30090863 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.28469890 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.21352326 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.19822721 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.13964419 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.07239729 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98575245 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.95992977 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93239271 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.89652545 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87130164 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86385312 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85070256 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84608862 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.84481583 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.82675106 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78782866 |
| 30 | GATA3_26560356_Chip-Seq_TH2_Human | 1.77618105 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.76002364 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.71627483 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66684424 |
| 34 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.65882901 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.63225718 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.61060901 |
| 37 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.58994266 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.58312057 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.48338126 |
| 40 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43826292 |
| 41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39881684 |
| 42 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.38849603 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35950699 |
| 44 | AR_20517297_ChIP-Seq_VCAP_Human | 1.33163401 |
| 45 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.32419239 |
| 46 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.31723778 |
| 47 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.28607320 |
| 48 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26383363 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23710763 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23119288 |
| 51 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.23078263 |
| 52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22813238 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21941068 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19497668 |
| 55 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19040549 |
| 56 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17794507 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16480513 |
| 58 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16347548 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16347548 |
| 60 | NCOR_22424771_ChIP-Seq_293T_Human | 1.15926541 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15285753 |
| 62 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14308000 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14090199 |
| 64 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13896079 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12439515 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10938715 |
| 67 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.08976703 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08898231 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08073659 |
| 70 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.07982143 |
| 71 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.07745672 |
| 72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07146577 |
| 73 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06854172 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03233910 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03137596 |
| 76 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.00864192 |
| 77 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00025406 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99783826 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99617683 |
| 80 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99271358 |
| 81 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99271358 |
| 82 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99221714 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99135296 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98846966 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97437482 |
| 86 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96853307 |
| 87 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.96525903 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95413276 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 0.95284332 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95197658 |
| 91 | GATA3_26560356_Chip-Seq_TH1_Human | 0.94486285 |
| 92 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.93651380 |
| 93 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93454503 |
| 94 | MAF_26560356_Chip-Seq_TH1_Human | 0.92922279 |
| 95 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92750057 |
| 96 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.92693679 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91570239 |
| 98 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.90918727 |
| 99 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.89300787 |
| 100 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.89073313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.29535980 |
| 2 | MP0009785_altered_susceptibility_to | 3.39907283 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.24470868 |
| 4 | MP0002102_abnormal_ear_morphology | 2.82366790 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.80773750 |
| 6 | MP0002166_altered_tumor_susceptibility | 2.61784967 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.41473994 |
| 8 | MP0001800_abnormal_humoral_immune | 2.37961583 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.33106070 |
| 10 | MP0004147_increased_porphyrin_level | 2.26156443 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.19905463 |
| 12 | MP0005025_abnormal_response_to | 2.19007301 |
| 13 | MP0002723_abnormal_immune_serum | 2.18604248 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.18091331 |
| 15 | MP0001819_abnormal_immune_cell | 2.12972569 |
| 16 | MP0003866_abnormal_defecation | 2.10482158 |
| 17 | MP0002006_tumorigenesis | 2.07927893 |
| 18 | MP0006072_abnormal_retinal_apoptosis | 2.03002360 |
| 19 | MP0006082_CNS_inflammation | 1.98391628 |
| 20 | MP0003786_premature_aging | 1.93349477 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.84110289 |
| 22 | MP0005387_immune_system_phenotype | 1.76951731 |
| 23 | MP0001790_abnormal_immune_system | 1.76951731 |
| 24 | MP0001873_stomach_inflammation | 1.75331590 |
| 25 | MP0002933_joint_inflammation | 1.72685476 |
| 26 | MP0002398_abnormal_bone_marrow | 1.68546577 |
| 27 | MP0000716_abnormal_immune_system | 1.67693042 |
| 28 | MP0000372_irregular_coat_pigmentation | 1.63271701 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.60312038 |
| 30 | MP0002736_abnormal_nociception_after | 1.58470504 |
| 31 | MP0002405_respiratory_system_inflammati | 1.57057601 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.56213298 |
| 33 | MP0000685_abnormal_immune_system | 1.53493890 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.51924536 |
| 35 | MP0002722_abnormal_immune_system | 1.44389686 |
| 36 | MP0003045_fibrosis | 1.44383159 |
| 37 | MP0003724_increased_susceptibility_to | 1.43503673 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.39849317 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.39486746 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.36109834 |
| 41 | MP0003878_abnormal_ear_physiology | 1.33241063 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.33241063 |
| 43 | MP0001968_abnormal_touch/_nociception | 1.33056709 |
| 44 | MP0005253_abnormal_eye_physiology | 1.31334995 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.30638158 |
| 46 | MP0008789_abnormal_olfactory_epithelium | 1.27835513 |
| 47 | MP0002429_abnormal_blood_cell | 1.27479573 |
| 48 | MP0001905_abnormal_dopamine_level | 1.22915317 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.19013596 |
| 50 | MP0003448_altered_tumor_morphology | 1.18298316 |
| 51 | MP0008872_abnormal_physiological_respon | 1.17632397 |
| 52 | MP0001853_heart_inflammation | 1.17394719 |
| 53 | MP0003436_decreased_susceptibility_to | 1.16448355 |
| 54 | MP0001919_abnormal_reproductive_system | 1.14586033 |
| 55 | MP0002419_abnormal_innate_immunity | 1.14452105 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.14321996 |
| 57 | MP0009764_decreased_sensitivity_to | 1.09732539 |
| 58 | MP0005410_abnormal_fertilization | 1.05440161 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.03169794 |
| 60 | MP0009763_increased_sensitivity_to | 1.02489074 |
| 61 | MP0001984_abnormal_olfaction | 1.00767386 |
| 62 | MP0008469_abnormal_protein_level | 1.00262956 |
| 63 | MP0003646_muscle_fatigue | 0.98981001 |
| 64 | MP0008995_early_reproductive_senescence | 0.97574595 |
| 65 | MP0003137_abnormal_impulse_conducting | 0.94589295 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 0.94012941 |
| 67 | MP0005389_reproductive_system_phenotype | 0.93800577 |
| 68 | MP0008875_abnormal_xenobiotic_pharmacok | 0.92961067 |
| 69 | MP0002653_abnormal_ependyma_morphology | 0.91996877 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 0.88643704 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.88004868 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.85623696 |
| 73 | MP0002876_abnormal_thyroid_physiology | 0.85259760 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 0.83624941 |
| 75 | MP0003011_delayed_dark_adaptation | 0.83444838 |
| 76 | MP0002009_preneoplasia | 0.83160866 |
| 77 | MP0002163_abnormal_gland_morphology | 0.83048382 |
| 78 | MP0010386_abnormal_urinary_bladder | 0.82471148 |
| 79 | MP0002234_abnormal_pharynx_morphology | 0.80832216 |
| 80 | MP0006276_abnormal_autonomic_nervous | 0.79836726 |
| 81 | MP0002019_abnormal_tumor_incidence | 0.79087345 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.79052350 |
| 83 | MP0001764_abnormal_homeostasis | 0.78183784 |
| 84 | MP0005499_abnormal_olfactory_system | 0.76615195 |
| 85 | MP0005394_taste/olfaction_phenotype | 0.76615195 |
| 86 | MP0003252_abnormal_bile_duct | 0.76220524 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.75927899 |
| 88 | MP0005646_abnormal_pituitary_gland | 0.75853033 |
| 89 | MP0006054_spinal_hemorrhage | 0.75672684 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.73662730 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.72150387 |
| 92 | MP0004885_abnormal_endolymph | 0.72113715 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.71713796 |
| 94 | MP0001188_hyperpigmentation | 0.71093108 |
| 95 | MP0005360_urolithiasis | 0.71007373 |
| 96 | MP0001529_abnormal_vocalization | 0.68661104 |
| 97 | MP0001542_abnormal_bone_strength | 0.68361268 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.68186249 |
| 99 | MP0004043_abnormal_pH_regulation | 0.66384589 |
| 100 | MP0001119_abnormal_female_reproductive | 0.65218635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.81829373 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.50757245 |
| 3 | Aplastic anemia (HP:0001915) | 5.26862716 |
| 4 | IgG deficiency (HP:0004315) | 4.67566528 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 4.45499370 |
| 6 | Hypoproteinemia (HP:0003075) | 4.16746897 |
| 7 | Abnormality of T cells (HP:0002843) | 3.98529911 |
| 8 | Abnormality of the prostate (HP:0008775) | 3.89654148 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 3.82405682 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.67412804 |
| 11 | Combined immunodeficiency (HP:0005387) | 3.48668646 |
| 12 | Thyroiditis (HP:0100646) | 3.30886379 |
| 13 | Chronic diarrhea (HP:0002028) | 3.28123032 |
| 14 | Mitochondrial inheritance (HP:0001427) | 3.26901779 |
| 15 | Hepatocellular necrosis (HP:0001404) | 3.18354405 |
| 16 | Increased IgM level (HP:0003496) | 3.18321264 |
| 17 | Abnormality of eosinophils (HP:0001879) | 3.16518636 |
| 18 | Increased intramyocellular lipid droplets (HP:0012240) | 3.02228396 |
| 19 | Pancytopenia (HP:0001876) | 2.94959249 |
| 20 | Abnormality of B cell number (HP:0010975) | 2.89383288 |
| 21 | Abolished electroretinogram (ERG) (HP:0000550) | 2.87870311 |
| 22 | 3-Methylglutaconic aciduria (HP:0003535) | 2.83958005 |
| 23 | Renal cortical cysts (HP:0000803) | 2.83941565 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 2.82147709 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 2.81791180 |
| 26 | Hepatic necrosis (HP:0002605) | 2.80664820 |
| 27 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.79614905 |
| 28 | Stomatitis (HP:0010280) | 2.75430048 |
| 29 | IgM deficiency (HP:0002850) | 2.69332772 |
| 30 | Increased CSF lactate (HP:0002490) | 2.66432273 |
| 31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.64030874 |
| 32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.64030874 |
| 33 | Oral leukoplakia (HP:0002745) | 2.63736104 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 2.63422064 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.63231862 |
| 36 | Lymphopenia (HP:0001888) | 2.55777071 |
| 37 | Amyotrophic lateral sclerosis (HP:0007354) | 2.53901389 |
| 38 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.51476817 |
| 39 | Encephalitis (HP:0002383) | 2.50818085 |
| 40 | Pancreatic cysts (HP:0001737) | 2.46093113 |
| 41 | B lymphocytopenia (HP:0010976) | 2.45560708 |
| 42 | Increased muscle lipid content (HP:0009058) | 2.42907994 |
| 43 | Recurrent bronchitis (HP:0002837) | 2.42227540 |
| 44 | Congenital stationary night blindness (HP:0007642) | 2.39615830 |
| 45 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38626659 |
| 46 | Ureteral stenosis (HP:0000071) | 2.32835587 |
| 47 | Abnormality of male internal genitalia (HP:0000022) | 2.31719390 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.31683887 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31439381 |
| 50 | Obstructive lung disease (HP:0006536) | 2.31439381 |
| 51 | Progressive macrocephaly (HP:0004481) | 2.31208704 |
| 52 | Abnormality of T cell physiology (HP:0011840) | 2.31032055 |
| 53 | Lipid accumulation in hepatocytes (HP:0006561) | 2.26719549 |
| 54 | Autoimmune thrombocytopenia (HP:0001973) | 2.24396750 |
| 55 | Type I transferrin isoform profile (HP:0003642) | 2.24293822 |
| 56 | Pulmonary fibrosis (HP:0002206) | 2.22557987 |
| 57 | Hypoalbuminemia (HP:0003073) | 2.22218765 |
| 58 | Abnormal albumin level (HP:0012116) | 2.22218765 |
| 59 | Eosinophilia (HP:0001880) | 2.21396647 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.20765122 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.20765122 |
| 62 | Abnormality of the renal cortex (HP:0011035) | 2.20013742 |
| 63 | Acute encephalopathy (HP:0006846) | 2.18292747 |
| 64 | Gangrene (HP:0100758) | 2.18012146 |
| 65 | Ureteral obstruction (HP:0006000) | 2.17746077 |
| 66 | Meningitis (HP:0001287) | 2.17089449 |
| 67 | Chest pain (HP:0100749) | 2.14415699 |
| 68 | Retinal dysplasia (HP:0007973) | 2.12563385 |
| 69 | Lymphoma (HP:0002665) | 2.11762184 |
| 70 | Abnormality of midbrain morphology (HP:0002418) | 2.09075732 |
| 71 | Molar tooth sign on MRI (HP:0002419) | 2.09075732 |
| 72 | Panhypogammaglobulinemia (HP:0003139) | 2.05138609 |
| 73 | Pancreatic fibrosis (HP:0100732) | 2.03468854 |
| 74 | Vasculitis (HP:0002633) | 2.03374876 |
| 75 | Increased serum lactate (HP:0002151) | 2.02762153 |
| 76 | True hermaphroditism (HP:0010459) | 2.02472830 |
| 77 | Joint swelling (HP:0001386) | 2.00621478 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.00423680 |
| 79 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.00417583 |
| 80 | Leukocytosis (HP:0001974) | 1.99023009 |
| 81 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.98657558 |
| 82 | Medial flaring of the eyebrow (HP:0010747) | 1.96363889 |
| 83 | Methylmalonic acidemia (HP:0002912) | 1.95546549 |
| 84 | Attenuation of retinal blood vessels (HP:0007843) | 1.94485294 |
| 85 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93448401 |
| 86 | Optic disc pallor (HP:0000543) | 1.90707169 |
| 87 | Type 2 muscle fiber atrophy (HP:0003554) | 1.88954085 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 1.88632109 |
| 89 | Bronchitis (HP:0012387) | 1.87252072 |
| 90 | Lactic acidosis (HP:0003128) | 1.84715881 |
| 91 | Methylmalonic aciduria (HP:0012120) | 1.84264976 |
| 92 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.83769455 |
| 93 | Myositis (HP:0100614) | 1.83141439 |
| 94 | Neonatal respiratory distress (HP:0002643) | 1.82227266 |
| 95 | Prostate neoplasm (HP:0100787) | 1.82211571 |
| 96 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.81227615 |
| 97 | Recurrent viral infections (HP:0004429) | 1.80978353 |
| 98 | Cerebral edema (HP:0002181) | 1.79423415 |
| 99 | Granulocytopenia (HP:0001913) | 1.79064192 |
| 100 | Type II lissencephaly (HP:0007260) | 1.78926109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.81889402 |
| 2 | KDR | 5.18022087 |
| 3 | TESK2 | 4.53892093 |
| 4 | TAOK3 | 3.10467677 |
| 5 | MAP4K1 | 2.74148939 |
| 6 | MAP4K2 | 2.42972363 |
| 7 | ITK | 2.33791546 |
| 8 | BCKDK | 2.23507835 |
| 9 | VRK2 | 2.04832265 |
| 10 | TESK1 | 2.03219385 |
| 11 | LIMK1 | 2.00854385 |
| 12 | SCYL2 | 1.93750482 |
| 13 | ADRBK2 | 1.92164546 |
| 14 | FES | 1.67501392 |
| 15 | STK16 | 1.61720475 |
| 16 | TEC | 1.60823034 |
| 17 | BCR | 1.60062813 |
| 18 | GRK1 | 1.54292914 |
| 19 | BUB1 | 1.54280120 |
| 20 | TIE1 | 1.48998066 |
| 21 | SYK | 1.41982773 |
| 22 | TLK1 | 1.41152150 |
| 23 | ZAK | 1.36932939 |
| 24 | GRK6 | 1.36676744 |
| 25 | VRK1 | 1.33195095 |
| 26 | IKBKE | 1.27611800 |
| 27 | TBK1 | 1.21986423 |
| 28 | TRIM28 | 1.13628842 |
| 29 | MAP3K12 | 1.10654789 |
| 30 | LCK | 1.10087037 |
| 31 | MST4 | 1.08746869 |
| 32 | BTK | 1.06880156 |
| 33 | IKBKB | 1.04560608 |
| 34 | PRKCQ | 1.03169697 |
| 35 | GRK7 | 0.96723720 |
| 36 | CSK | 0.96188999 |
| 37 | NUAK1 | 0.95847232 |
| 38 | RPS6KA4 | 0.87847156 |
| 39 | CSF1R | 0.87374641 |
| 40 | MAPKAPK3 | 0.86818996 |
| 41 | DAPK1 | 0.86591759 |
| 42 | ZAP70 | 0.86367762 |
| 43 | LYN | 0.85339603 |
| 44 | CSNK1G3 | 0.83180550 |
| 45 | ERBB3 | 0.79818247 |
| 46 | MAP2K7 | 0.77549326 |
| 47 | MAP3K11 | 0.76693463 |
| 48 | MATK | 0.75966349 |
| 49 | FRK | 0.75332859 |
| 50 | CAMKK2 | 0.75070136 |
| 51 | MAP2K6 | 0.73010725 |
| 52 | WNK4 | 0.72773245 |
| 53 | KIT | 0.72635684 |
| 54 | MAPK13 | 0.70160955 |
| 55 | SRPK1 | 0.68337801 |
| 56 | EIF2AK3 | 0.67692816 |
| 57 | TNK2 | 0.66365376 |
| 58 | BMPR1B | 0.65829602 |
| 59 | BMPR2 | 0.63626700 |
| 60 | INSRR | 0.62733054 |
| 61 | WNK3 | 0.58486722 |
| 62 | CSNK1A1L | 0.57562571 |
| 63 | PASK | 0.57107723 |
| 64 | CDK19 | 0.56758117 |
| 65 | CSNK1G2 | 0.56348607 |
| 66 | IGF1R | 0.55385032 |
| 67 | RPS6KA5 | 0.55338777 |
| 68 | OXSR1 | 0.52859413 |
| 69 | MYLK | 0.52686310 |
| 70 | RIPK4 | 0.51431651 |
| 71 | PIK3CG | 0.50320247 |
| 72 | FYN | 0.49582130 |
| 73 | OBSCN | 0.49085840 |
| 74 | CSNK1G1 | 0.48771137 |
| 75 | MAP3K14 | 0.45420183 |
| 76 | GRK5 | 0.44977467 |
| 77 | JAK3 | 0.38048811 |
| 78 | PIM1 | 0.35582053 |
| 79 | MAP3K4 | 0.34405167 |
| 80 | PRKCA | 0.33384113 |
| 81 | MAP3K5 | 0.33118768 |
| 82 | ABL1 | 0.32630144 |
| 83 | STK39 | 0.31955048 |
| 84 | AURKA | 0.31536871 |
| 85 | INSR | 0.30834545 |
| 86 | PIM2 | 0.30587102 |
| 87 | EIF2AK2 | 0.30157119 |
| 88 | ATR | 0.28751509 |
| 89 | CSNK2A1 | 0.27887637 |
| 90 | PRKACA | 0.26381419 |
| 91 | PIK3CA | 0.23862139 |
| 92 | CAMK2A | 0.23551364 |
| 93 | CAMKK1 | 0.23336881 |
| 94 | BLK | 0.23024731 |
| 95 | PLK2 | 0.22900408 |
| 96 | NME1 | 0.22841151 |
| 97 | ROCK1 | 0.22800260 |
| 98 | CCNB1 | 0.22153325 |
| 99 | MAPKAPK2 | 0.21825347 |
| 100 | PINK1 | 0.21792081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.60922354 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.80352765 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.14155903 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.05475702 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.94416181 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.79241665 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.61329813 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.50108344 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.46910940 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.42771025 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.29091420 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.24638429 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.19154874 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.92461107 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.82251009 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.78807238 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.78393027 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.50538026 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43871940 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.42352386 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38475363 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36689771 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31195551 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31155212 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.25205370 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15751228 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.15613233 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09963957 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.09447862 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09360652 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08947962 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08038214 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.05590754 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.03841293 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99850994 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99683912 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99610580 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98587567 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 0.92673319 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89140375 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88299660 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86968030 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86648029 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.85255667 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83282125 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 0.82658305 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82540758 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80455229 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76691178 |
| 50 | Spliceosome_Homo sapiens_hsa03040 | 0.75967405 |
| 51 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69716873 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 0.68533194 |
| 53 | Purine metabolism_Homo sapiens_hsa00230 | 0.68379531 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68363300 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68127944 |
| 56 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67281523 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 0.66428153 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61563155 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57997344 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57281411 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57211909 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.57017239 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56879114 |
| 64 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56741668 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55615788 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.53810689 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52406290 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52379525 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52343405 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51645250 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.51353423 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49046388 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45705451 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45674439 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44218585 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42657022 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41856422 |
| 78 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41801628 |
| 79 | Legionellosis_Homo sapiens_hsa05134 | 0.41730120 |
| 80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41576868 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39377086 |
| 82 | Taste transduction_Homo sapiens_hsa04742 | 0.39308745 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37332891 |
| 84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36025656 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.35312345 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33495255 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32489936 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.30463624 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29348560 |
| 90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28578896 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27516469 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26984538 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26296091 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.25785474 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.25756207 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25311632 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25140552 |
| 98 | RNA transport_Homo sapiens_hsa03013 | 0.24464244 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.24155650 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.23900745 |

